Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Jellagen logo — A Revolutionary Platform for Regenerative Medicine

Jellagen

A Revolutionary Platform for Regenerative Medicine

Founded 2015 United Kingdom Cardiff, United Kingdom 15 employees Series A Total: $14.36M Biotechnology, Health Care +1

General Information

Company Name Jellagen
Founded Year 2015
Location United Kingdom Cardiff, United Kingdom
Founders / Decision Makers
Team member
Employees 15
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Jellagen. To contact Jellagen, visit jellagen.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Jellagen compare?

A PDF of Jellagen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Jellagen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Jellagen

Jellagen is a biotechnology and healthcare startup headquartered in the United Kingdom that has attracted significant attention with its revolutionary platform for regenerative medicine. Since its founding in 2013, the company has been dedicated to addressing complex regenerative medical needs and shaping next-generation treatments. At the core of their innovation is marine-sourced Collagen Type 0, an ancient stem collagen that enables a wide range of applications across multiple indications. This unique approach has garnered substantial interest, leading to a notable £8.70M Series A investment on December 7, 2022. The investment was secured from prominent backers including the Development Bank of Wales, Cardiff Capital Region, and the Thai Union Group. Jellagen's focus on leveraging jellyfish collagen for medical advancements has positioned it as a key player in the regenerative medicine space, making it a compelling prospect for investors seeking innovative opportunities in the healthcare sector.

Business keywords: Regenerative Medicine, Jellyfish Collagen, Marine Sourced Collagen, Stem Cell Research, Tissue Engineering, Medical Grade Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Marine Biotechnology, 3D Scaffolds, Collagen-Coated Plates, 3D Sponges

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A £8.70M 3
Development Bank of Wales Cardiff Capital Region
Development Bank of Wales, Cardiff Capital Region +1
07 Dec 2022
Venture Round £3.80M 2
Development Bank of Wales Newable Private Investing
Development Bank of Wales, Newable Private Investing
30 Apr 2018
Grant £329.09K 1
Innovate UK
Innovate UK
28 Jun 2017
Series A £1.53M 4
Development Bank of Wales Newable Private Investing xénos
Development Bank of Wales, Newable Private Investing +2
06 Apr 2016

Jellagen Alternatives & Competitors

View All Alternatives
Jellagen vs
Matrigen
Matrigen United States

Introducing Softwell®. It's coming to a lab near you.

2 employees
Biotechnology, Health Care
Jellagen vs
Aglaris Ltd Group
Aglaris Ltd Group United Kingdom

Aglaris Ltd. together with Aglaris Cell, Changing Cellular Manufacturing: More productive, more reli...

Grant
11 employees
Biotechnology, Health Care
Jellagen vs
Bonus Biogroup
Bonus Biogroup Israel

Innovation ★ Tissue Engineering ★ Cell Therapy ★ Impact

47 employees
Biotechnology, Health Care
View all alternatives

FAQ About Jellagen

A Revolutionary Platform for Regenerative Medicine
Jellagen was founded in 2015.
Jellagen is headquartered in Cardiff, United Kingdom.
Jellagen operates in Biotechnology, Health Care and Life Sciences. Its work centres on Regenerative Medicine, Jellyfish Collagen, Marine Sourced Collagen and Stem Cell Research.
Jellagen has approximately 15 employees.
Jellagen has completed 4 funding rounds, raising a total of $14.36M. The latest funding stage is Series A.
Top alternatives and competitors to Jellagen include Matrigen, Aglaris Ltd Group, Bonus Biogroup, VIDEREGEN LIMITED, CytoNiche. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Jellagen and Matrigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Jellagen, https://bouncewatch.com/company/jellagen, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes